iRhythm Technologies (IRTC) Financials

iRhythm Technologies Inc (IRTC) is a leading digital healthcare company that specializes in developing and commercializing advanced technologies for the diagnosis and management of cardiac arrhythmias. The company's financial performance has been strong, as reflected in its income statement. In the latest fiscal year, iRhythm Technologies Inc reported a significant increase in total revenue, reaching $285 million. This growth can be attributed to the rising demand for the company's innovative products and services.

One of the key metrics used to evaluate iRhythm Technologies Inc's profitability is EBIT (earnings before interest and taxes). In the latest fiscal year, the company's EBIT was $14 million. This indicates that iRhythm Technologies Inc was able to generate a healthy operating profit. Additionally, the company's EBITDA (earnings before interest, taxes, depreciation, and amortization) was $36 million, demonstrating its strong financial performance.

Gross profit is another important metric to consider when analyzing iRhythm Technologies Inc's financials. In the latest fiscal year, the company reported a gross profit of $190 million. This represents the amount of money left after deducting the cost of goods sold from the total revenue. It showcases the company's ability to efficiently manage its operations and generate revenue.

Net income from stockholders is an essential metric for investors, as it represents the amount of profit allocated to stockholders after deducting all expenses and taxes. In the latest fiscal year, iRhythm Technologies Inc reported a net income from stockholders of $10 million. This indicates that the company was able to generate a positive return for its shareholders.

Turning to the balance sheet, iRhythm Technologies Inc has a strong financial position with significant total assets. The company's total assets amount to $480 million, which includes cash equivalents, property, equipment, and other tangible and intangible assets. On the other hand, the company's total liabilities stand at $200 million, indicating a healthy debt-to-equity ratio.

A breakdown of the company's cash flow reveals a positive operating cash flow of $20 million. This indicates that iRhythm Technologies Inc is generating cash from its core operations. The company also has a positive investing cash flow of $5 million, suggesting that it is investing in its future growth and development. Additionally, iRhythm Technologies Inc has a financing cash flow of $10 million, which includes activities such as raising capital through debt or equity.

In conclusion, iRhythm Technologies Inc's financials reflect a strong and profitable company. With growing total revenue, positive net income from stockholders, and a healthy balance sheet, the company is well-positioned for future success in the digital healthcare industry.